Amundi Cuts Holdings in Oscar Health, Inc. $OSCR

Key Points

• Amundi sold 23,858 shares of Oscar Health, reducing its stake by 3.5% to approximately 666,796 shares, valued at $9.07 million as of the recent SEC filing.
• Multiple institutional investors have shown interest in Oscar Health, with notable increases in holdings by Larson Financial Group (83,733.3% increase) and CWM LLC (50.7% increase).
• Oscar Health's stock has faced significant downgrades, with price targets set as low as $10.00 by Wells Fargo, amidst a consensus rating of "Strong Sell" from analysts.

Amundi trimmed its holdings in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 3.5% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 666,796 shares of the company's stock after selling 23,858 shares during the quarter. Amundi owned approximately 0.27% of Oscar Health worth $9,075,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Southeastern Asset Management Inc. TN boosted its stake in Oscar Health by 52.2% in the fourth quarter. Southeastern Asset Management Inc. TN now owns 3,131,084 shares of the company's stock valued at $42,082,000 after acquiring an additional 1,073,359 shares in the last quarter. Man Group plc boosted its stake in Oscar Health by 344.8% in the fourth quarter. Man Group plc now owns 1,813,216 shares of the company's stock valued at $24,370,000 after acquiring an additional 1,405,554 shares in the last quarter. Victory Capital Management Inc. boosted its stake in Oscar Health by 23.8% in the first quarter. Victory Capital Management Inc. now owns 285,997 shares of the company's stock valued at $3,749,000 after acquiring an additional 54,938 shares in the last quarter. Toronto Dominion Bank acquired a new stake in Oscar Health in the fourth quarter valued at approximately $1,008,000. Finally, Concurrent Investment Advisors LLC acquired a new stake in Oscar Health in the first quarter valued at approximately $677,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

Oscar Health Stock Performance

NYSE OSCR traded down $0.10 on Friday, reaching $19.33. 10,863,907 shares of the company's stock traded hands, compared to its average volume of 17,290,522. The firm has a market cap of $5.00 billion, a price-to-earnings ratio of -23.86 and a beta of 1.87. The stock has a 50 day moving average price of $15.92 and a 200-day moving average price of $15.15. Oscar Health, Inc. has a fifty-two week low of $11.20 and a fifty-two week high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.86 and a current ratio of 0.86.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.90) by $0.01. The company had revenue of $2.86 billion during the quarter, compared to the consensus estimate of $2.88 billion. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The firm's quarterly revenue was up 29.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.20 earnings per share. Equities research analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Wall Street Analyst Weigh In

OSCR has been the subject of several research reports. Raymond James Financial downgraded shares of Oscar Health from an "outperform" rating to a "market perform" rating in a research note on Tuesday, June 24th. Wall Street Zen downgraded shares of Oscar Health from a "hold" rating to a "sell" rating in a research note on Saturday, August 9th. Baird R W downgraded shares of Oscar Health from a "strong-buy" rating to a "hold" rating in a research note on Friday, July 25th. UBS Group reiterated a "sell" rating and set a $11.00 price objective (down from $15.00) on shares of Oscar Health in a research note on Tuesday, July 15th. Finally, Wells Fargo & Company downgraded shares of Oscar Health from an "equal weight" rating to an "underweight" rating and lowered their price objective for the stock from $16.00 to $10.00 in a research note on Friday, July 11th. Four research analysts have rated the stock with a Hold rating and five have issued a Sell rating to the stock. According to MarketBeat.com, Oscar Health has an average rating of "Strong Sell" and a consensus price target of $12.07.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.